BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan Y, Zaidi SO, Razak BS, Zaki M, Malik BH. Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients. Cureus 2020;12:e7007. [PMID: 32206471 DOI: 10.7759/cureus.7007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang CL, Wu VC, Tu HT, Huang YT, Chen SW, Chu PH, Wen MS, Huang HL, Chang SH. Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation. J Thromb Thrombolysis 2021. [PMID: 34557973 DOI: 10.1007/s11239-021-02570-9] [Reference Citation Analysis]
2 Reçber T, Haznedaroğlu İC, Çelebier M. Review on Characteristics and Analytical Methods of Rivaroxaban. Critical Reviews in Analytical Chemistry. [DOI: 10.1080/10408347.2020.1839735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Cao P, Jiang L, Zhou LY, Chen YL. The clinical significance of preoperative serum fibrinogen levels and platelet counts in patients with gallbladder carcinoma. BMC Gastroenterol 2021;21:366. [PMID: 34620100 DOI: 10.1186/s12876-021-01943-x] [Reference Citation Analysis]